Centralized multidisciplinary team assessment of metastasis resectability in patients with metastatic colorectal cancer: A fundamental necessity.
作者信息
André Thierry
机构信息
Department of Medical Oncology, Saint-Antoine Hospital, 184 Rue du Faubourg, 75012 Paris, France.
出版信息
Lancet Reg Health Eur. 2021 Feb 26;3:100058. doi: 10.1016/j.lanepe.2021.100058. eCollection 2021 Apr.
Abstract
摘要
相似文献
1
Centralized multidisciplinary team assessment of metastasis resectability in patients with metastatic colorectal cancer: A fundamental necessity.转移性结直肠癌患者转移灶可切除性的多学科团队集中评估：一项基本需求。
Lancet Reg Health Eur. 2021 Feb 26;3:100058. doi: 10.1016/j.lanepe.2021.100058. eCollection 2021 Apr.
2
Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.一线治疗期间结直肠癌肝转移患者集中重复可切除性评估：前瞻性研究。
Br J Surg. 2021 Jul 23;108(7):817-825. doi: 10.1093/bjs/znaa145.
3
Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study.对1086例芬兰转移性结直肠癌患者进行可切除性、临床行为及预后的重复集中多学科团队评估（RAXO）：一项全国性前瞻性干预研究。
Lancet Reg Health Eur. 2021 Jan 29;3:100049. doi: 10.1016/j.lanepe.2021.100049. eCollection 2021 Apr.
4
Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study).老年转移性结直肠癌患者的可切除性、切除术、生存结果及生活质量（RAXO研究）
J Clin Med. 2023 May 18;12(10):3541. doi: 10.3390/jcm12103541.
5
Multicentre study of multidisciplinary team assessment of pancreatic cancer resectability and treatment allocation.多中心研究：多学科团队对胰腺癌可切除性和治疗分配的评估。
Br J Surg. 2019 May;106(6):756-764. doi: 10.1002/bjs.11093. Epub 2019 Mar 4.
6
Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer.癌胚抗原放射免疫检测和计算机断层扫描在预测复发性结直肠癌可切除性中的应用。
Ann Surg. 1997 Nov;226(5):621-31. doi: 10.1097/00000658-199711000-00007.
7
[Chinese expert consensus on multidisciplinary treatment of bone metastasis from colorectal cancer (2020 version)].《中国结直肠癌骨转移多学科综合治疗专家共识（2020年版）》
Zhonghua Zhong Liu Za Zhi. 2020 Jun 23;42(6):433-437. doi: 10.3760/cma.j.cn112152-20200402-00295.
8
The Effect of Multidisciplinary Team Discussion Intervention on the Prognosis of Advanced Colorectal Cancer.多学科团队讨论干预对晚期结直肠癌预后的影响
J Cancer. 2021 Apr 7;12(11):3307-3314. doi: 10.7150/jca.56171. eCollection 2021.
9
'Liver-first' approach for metastatic colorectal cancer.转移性结直肠癌的“肝优先”治疗方法
Future Oncol. 2015;11(8):1233-43. doi: 10.2217/fon.14.316.
10
Surgical and Interventional Management of Lung Metastasis: Surgical Assessment, Resection, Ablation, Percutaneous Interventions.肺转移瘤的手术及介入治疗：手术评估、切除、消融、经皮介入治疗
Clin Colon Rectal Surg. 2022 Nov 29;37(2):85-89. doi: 10.1055/s-0042-1758823. eCollection 2024 Mar.
引用本文的文献
1
Synchronous metastases from colorectal cancer. Treatment and long-term survival compared to patients with metachronous metastases: a population-based study from Central Norway 2001-2015.结直肠癌的同时性转移。与异时性转移患者相比的治疗及长期生存情况：一项基于挪威中部2001 - 2015年人群的研究
Acta Oncol. 2025 Jun 18;64:797-806. doi: 10.2340/1651-226X.2025.42985.
本文引用的文献
1
Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study.对1086例芬兰转移性结直肠癌患者进行可切除性、临床行为及预后的重复集中多学科团队评估（RAXO）：一项全国性前瞻性干预研究。
Lancet Reg Health Eur. 2021 Jan 29;3:100049. doi: 10.1016/j.lanepe.2021.100049. eCollection 2021 Apr.
2
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.帕博利珠单抗治疗微卫星高度不稳定型晚期结直肠癌。
N Engl J Med. 2020 Dec 3;383(23):2207-2218. doi: 10.1056/NEJMoa2017699.
3
Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons: A Throw of the Dice?专家肝脏外科医师治疗结直肠肝转移的策略选择：掷骰子？
Ann Surg. 2020 Nov;272(5):715-722. doi: 10.1097/SLA.0000000000004331.
4
Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real-life data.基于真实数据量化生存时间的多种情景，从而为转移性结直肠癌患者提供信息。
Int J Cancer. 2021 Jan 15;148(2):296-306. doi: 10.1002/ijc.33200. Epub 2020 Jul 20.
5
Debulking surgery for colorectal liver metastases: Foolish or chance?结直肠肝转移瘤的肿瘤切除术：愚蠢之举还是偶然为之？
Surg Oncol. 2020 Jun;33:266-269. doi: 10.1016/j.suronc.2020.02.008. Epub 2020 Feb 15.
6
Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019).上海共识：结直肠癌肝转移诊断和综合治疗（2019 版）
Eur J Surg Oncol. 2020 Jun;46(6):955-966. doi: 10.1016/j.ejso.2020.02.019. Epub 2020 Feb 20.
7
Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectives.优化非转移性结肠癌的辅助治疗：新标准和新视角。
Cancer Treat Rev. 2019 May;75:1-11. doi: 10.1016/j.ctrv.2019.02.002. Epub 2019 Feb 26.
8
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.ESMO 共识指南：转移性结直肠癌患者的管理。
Ann Oncol. 2016 Aug;27(8):1386-422. doi: 10.1093/annonc/mdw235. Epub 2016 Jul 5.
9
Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes.基于多学科团队（MDTs）重组癌症服务是否值得？对多学科团队的目标、组织及其对患者预后的影响进行的系统评价。
Health Policy. 2015 Apr;119(4):464-74. doi: 10.1016/j.healthpol.2014.09.006. Epub 2014 Sep 18.
10
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.围手术期 FOLFOX4 化疗联合手术与单纯手术治疗结直肠癌可切除肝转移（EORTC 40983）：一项随机、对照、3 期临床试验的长期结果。
Lancet Oncol. 2013 Nov;14(12):1208-15. doi: 10.1016/S1470-2045(13)70447-9. Epub 2013 Oct 11.
Zotero 插件